Patent details

Basic Information

Publication number:

EP2596364

PCT Application Number:

PCT/EP/2011/062226

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117486019

PCT Publication Number:

WO/2012/010546

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF PANCREATIC CANCER

French Title of Invention:

BIOMARQUEURS DU PLASMA SANGUIN POUR DES POLYTHÉRAPIES À BASE DE BEVACIZUMAB, DANS LE TRAITEMENT DU CANCER DU PANCRÉAS

German Title of Invention:

BLUTPLASMABIOMARKER FÜR BEVACIZUMAB-KOMBINATIONSTHERAPIEN ZUR BEHANDLUNG VON PANKREASKARZINOM

SPC Number:

Dates

Filing date:

18/07/2011

Grant date:

16/12/2015

EP Publication Date:

16/12/2015

PCT Publication Date:

26/01/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/05/2013

EP B1 Publication Date:

16/12/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/07/2016

Expiration date:

18/07/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/07/2011

 

 

Name:

F.Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

SCHERER Stefan

Address:

United States (US)

2

Name:

KRAUSE Friedemann

Address:

Germany (DE)

3

Name:

DELMAR Paul

Address:

Switzerland (CH)

4

Name:

FOERNZLER Dorothee

Address:

Switzerland (CH)

Priority

Priority Number:

10170004

Priority Date:

19/07/2010

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

G01N 33/574;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages